New Data Supports Use Of Epidiolex In Tuberous Sclerosis Complex
Jazz Pharmaceuticals has shared new data on Epidiolex in patients with tuberous sclerosis complex (TSC).
24 results for “epidiolex”
Jazz Pharmaceuticals has shared new data on Epidiolex in patients with tuberous sclerosis complex (TSC).
The development puts VER-01 in prime position to become the first FDA-approved cannabis-derived medicine for pain.
A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
After a six-year battle on behalf of campaigners, Romania’s Health Committee has rejected a bill which would broaden access to medical cannabis products on prescription. Following […]
Six years on from the legalisation of medical cannabis in the UK, new figures reveal lack of NHS prescribing.
Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders.
A new bill has opened the door for the establishment of a medical cannabis and industrial hemp industry.
A new report highlights the breakthroughs and barriers in the pharmaceutical cannabis space over the last 13 years.
The UK saw the second highest number of clinical trials on cannabinoids in the last decade, the majority linked to GW Pharmaceuticals.
There are three times more cannabis social clubs than McDonald’s locations in Spain, so why can patients still not access their medicine legally?
An expert answers some frequently asked questions about the use of cannabis in paediatric epilepsy.
An expert explores the need for more clinician education around cannabis.
Advocates in the UK are calling for their own government to follow suit and invest in much-needed NHS trials.
The company has shared new findings on its role in treating seizures related to rare forms of epilepsy.
Researchers found limited evidence, however, to support its efficacy at doses lower than 400mg.
The whole-plant product was more a more effective inhibitor of sodium channels in epilepsy.
The cannabis-based drug is prescribed on the NHS to treat spasticity in multiple sclerosis (MS).
The MHRA has removed a compassionate licence for the import of Celixir20 – which many children currently rely on.
Medical cannabis is a genuine alternative for people battling a variety of health conditions
Two experts on how to understand the limitations of cannabis studies.
Some major UK health charities say they want to see medical cannabis prescribed on the NHS.
Andrew Megahy, lead science officer at Always Pure Organics, explains more about CBDA and CBGA.
When it comes to epilepsy, we examine if CBD could help with managing the symptoms
Katrina Boulton is helping others access medical cannabis after seeing its effects on her daughter.